chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient had seizure approximately 3 hours after immunizations.  Mother denied fever at that time.  Child was taken to ED for Rx.
Developed: Est 2.5cm erythema with increased warmth and tenderness in R upper arm medially to pneumococcal injection site. ~24 hours after injection. Pt started on AUGMETIN and ZYRTEC.
I received my vaccine on 11/18/2021 and 7 days later 11/25/21 was when I began having symptoms walking into a family members house and the smell of the turkey that was cooking  making me nauseous.  Food was unbearable to eat and when I had a drink of a soda I knew that something was very off. Most food smells and tastes like rotten meat or eggs. Particularly meats whether they are raw, cooking or are ready to be eaten. Other foods taste rotten and smoky at the same time. Coffee and soda also taste like garbage. Certain vegetables smell and taste like they are bad or rotten. Various different things do not smell as they should. Gasoline smells the same as the food I have to eat and drink and if I wasn't able to see I would not be able to tell the difference between food or gasoline. From what I have found all of the symptoms I have are caused by parosmia. Symptoms continue and I haven't seen any improvement thus far.
A short time after receiving the vaccine I began experiencing a constant low buzzing and a ringing in my ears that has not gone away. I do not have a history of tinnitus or anything like it. It is extremely unnerving. I think it is related to a reaction to the vaccine. Incidentally, while not the adverse effect I am reporting, I developed a resurgence of left arm injection site pain and a small bruise about 14 days after the shot that has lasted for days.
No symptoms afterward except soreness at injection site. On the 8th day a rash appeared at the injection site. There is slight soreness with the rash and it is warm to the touch. The rash is circular shaped approximately two inches in diameter. Similar to what others report as COVID arm.
6 doses administered beyond the expiration date (2 days Expired Moderna Vaccine); This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (6 doses administered beyond the expiration date (2 days Expired Moderna Vaccine)) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Nov-2021 at 3:10 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (6 doses administered beyond the expiration date (2 days Expired Moderna Vaccine)). On 08-Nov-2021, EXPIRED PRODUCT ADMINISTERED (6 doses administered beyond the expiration date (2 days Expired Moderna Vaccine)) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No side effects reported by the patient from the date the expired vaccine received.  No treatment medications were reported.     This case was linked to MOD-2021-381144 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 12-Nov-2021: Follow up information received contains non significant information. On 12-Nov-2021: significant follow up appended
6-8pm - Receiving 3 vaccines at health department - started with mod-severe headache, congested; runny nose; sore throat. Feverish, body aches. Symptoms continue 48 hours after vaccines. 10-19-12 Reinterviewed client. Headache, congestion continues 72 hours after FLUMIST.
Lethargy, fever, local erythema approximately 8-10cm (L thigh). Started within 24 hrs of administration. Seen four days later, still temp. 100.6 deg. F, lethargy and local reaction.
Severe pain in entire arm where vaccine was received about 12 hours after vaccine.  Swelling in upper left arm also 12 hours after. Fever, chills, muscles aches less that 48 hours after vaccine. Severity of arm pain has not changed after 48 hours.
states was driving home from VA and started having a lot of burning and itching to right ear then became short of breath
rash develop around the injection about 3 inches in diameter; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE RASH (rash develop around the injection about 3 inches in diameter) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced VACCINATION SITE RASH (rash develop around the injection about 3 inches in diameter). At the time of the report, VACCINATION SITE RASH (rash develop around the injection about 3 inches in diameter) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant drugs were not reported. Treatment drugs included Anti-biotic and Benadryl topical cream..   Most recent FOLLOW-UP information incorporated above includes: On 15-Apr-2021: outcome changed to resolved as per TCR received
Mom states within 10-15 minutes of administration patient complained of stomach ache. When got home, he looked a little pale. About 30 minutes after administration he was itching himself and mom noticed a rash of small red bumps developing on upper body and red around his eyes. She called the pharmacy about 445pm, we discussed administering BENADRYL and to call Dr.'s office. Doctor's office confirmed treatment plan and to watch for any signs of difficulty breathing. About 545pm, I called parent and was told patient was not any worse and that rash had moved down to lower extremities. There were no signs of problems breathing and will continue BENADRYL for 1-2 days.
Developed a bubble under the skin; Mild kind of soreness; Mild muscle soreness; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient) reported that a patient of unspecified age and gender received BNT162B2, via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient wanted to know if she can take Tylenol after getting her vaccination. She said after it she developed a bubble under the skin. The patient also experienced mild kind of soreness, just mild muscle soreness. The patient was just wondering if it is okay to take Tylenol for it. The outcome of the events was unknown.  No follow-up attempts are possible. Information about batch number cannot be obtained.
Tenderness, induration, erythema and itching at injection site; headache, fatigue, feeling cold, temp 100 (temporal),
Initial report received from another company and a health care professional on 1/19/2006. A six year old male patient with no medical history, had received a dose of Fluzone no preservative 2005-2006, lot number U1742JA, on 1/27/2005. The route and site of administration were not reported. Approximately one week post vaccination, the patient developed vomiting and a fever, which may have been as high as 103 degrees F as per the reporter. The patient was also achy, had joint pain and hip pain. X rays and MRI of the hip were negative. The reporter stated that the information was given to her by the patients mother, who reported that the patient seems to get better and then becomes worse again. The patient is currently being worked up for lyme disease. The reporter stated that she believed the patient was hospitalized for the events. He has not recovered and is under a physicians care.  (OMIC)
04:30pm mother called re: rash on abdomen, red raised and itching. Denies any breathing difficulty. Advised that mother seek medical appointment. At office visit shortly after call, rash on arms, abdomen and back. MD ordered Benadryl every 6 hours and told mother it was reaction to MMR vaccine. 3/13/2003, phoned call rash improved.
May have also had flu vaccine the same day or around the same time.   Had Pfizer Bivalent vaccine in right arm at a pharmacy on Sunday 9/11.  Next day he started to feel a pulling like discomfort/ buzzing sensation starting from back or right side of neck, down back, in the back of his R shoulder and the back of his arm, to his right 5th finger. Next day right arm was weaker.  Over several days after he noticed his right pectoral muscle drooping.  Seen by neurology and given a medrol dose pak 10/4/22. Return visit 10/31/22, improved strength right arm. Still with right pectoral muscle which appears smaller than right.
PATIENT WAS GIVEN 0.1 ML INSTEAD OF 0.5 ML OF MODERNA; PATIENT CONTACTED TO RESCHEDULE FOR FULL DOSE; STAFF WERE ALL PROVIDED ADDITIONAL TRAINING ?Moderna COVID-19 Vaccine EUA?
Pt was given Fluzone that expired on 6.30.23. Dr notified. Pt notified. Pt will monitor and call with any concerns.
Where the injection is there is a bump and it is red around the injection site for about a circle of two or three inches. I feel sick to my stomach and my arm is really sore. I just don't feel well and I am concerned about the site being red and swollen.
Temp in the refigerator below 1.9 for apprx. 2 hrs. Action recalled client.
Mild flu like symptoms starting approximately 10 hours after injection. Symptoms included advertised body aches, fever, and chills with stuffy nose, sore throat, lightheaded most of day. Unable to eat much that day, sever loss of appetite. Symptoms Lasted approximately 36 hours. Then 3 days later had lymph node swelling in arm pit with extreme pain in vicinity. Lasted an additional week. Received 2nd shot 28 days later (today) currently have noticeably swollen upper shoulder area and loss of mobility, splitting headache.
Short term memory loss remembering things that had occurred/been talked about the day before; Extremly lethargic; Could barely stay awake; This spontaneous case from was received on 04-Dec-2020 from other non-health professional via Agency (reference number: SEQW20-05578) and concerned a male patient of an unknown age.  The patient's medical history and concomitant medications were not reported.  On 16-Nov-2020, the patient was vaccinated with Afluria Quadrivalent (influenza vaccine, dose, route of administration, anatomical location and indication: not reported). The batch number reported was P100249167.  On 17-Nov-2020, one day after receiving Afluria Quadrivalent, the patient was extremely lethargic, could barely stay awake at work and had some short-term memory loss remembering things that had occurred/been talked about the day before. These symptoms were very extreme and things the patient had never experienced before.   On an unspecified date in Nov-2020, the patient recovered from events, as the symptoms lasted roughly a week.  The reporter did not provide a causality assessment.  The event of 'short-term memory loss' was considered to be medically significant by a Physician.  Company comment: A male patient of unknown age developed amnesia, lethargy and somnolence one day after vaccination with the suspect product, Afluria Quadrivalent. Information regarding the underlying medical history and concomitant medications have not been provided. Due to plausible time relationship, causality is assessed as possible (defaults to related in the safety database for reporting purposes).; Sender's Comments: A male patient of unknown age developed amnesia, lethargy and somnolence one day after vaccination with the suspect product, Afluria Quadrivalent. Information regarding the underlying medical history and concomitant medications have not been provided. Due to plausible time relationship, causality is assessed as possible (defaults to related in the safety database for reporting purposes).
fever of 100.4 degrees F 10 hours after booster dose of Shingrix. Fever lasted about 8 hours.
Patient received FLUZONE HD and PNEUMOVAX 23 on the same arm on 8/6/2018. Following administration, patient reports persistent pain and muscle weakness in that arm, leading to limited ability to pick up household objects and disruption of sleep.
Headache, Arthralgia, Fever, lethergic, chills, injection site swelling and pain Narrative:  Other Relevant History:
back muscle pain; arm redness; burning; muscle pain; soreness in arm; This case was reported by a consumer via interactive digital media and described the occurrence of erythema of extremities in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On 6th October 2022 16:00, the patient received the 1st dose of Shingles vaccine. On 7th October 2022, 1 days after receiving Shingles vaccine, the patient experienced muscular back pain. In October 2022, the patient experienced erythema of extremities, burning sensation, myalgia and pain in arm. On an unknown date, the outcome of the erythema of extremities, burning sensation, myalgia, pain in arm and muscular back pain were not recovered/not resolved.   It was unknown if the reporter considered the erythema of extremities, burning sensation, myalgia, pain in arm and muscular back pain to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 05-Oct-2022 Reporter's Comment: This case was reported by a patient via interactive digital media. The patient received the first dose of Shingles vaccine on Thursday at 4 pm. Less than a week after vaccination, the patient experienced usual arm redness, burning, muscle pain and soreness in my arm.  The patient got up Friday morning with back muscle pain. The patient still had it. The patient was asking could this be from the vaccine. Additional Supportive Information: The follow up would not possible as no contact details were available.
Increased heart rate/heart rate increased to 200 beats per minute; This is a spontaneous report from a contactable consumer (patient). A 61-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date were not reported), via an unspecified route of administration on unspecified date at a single dose in the left arm for covid-19 immunization. Medical history included high blood pressure from 2017 and ongoing, open heart surgery in Aug2017 (for two holes in her heart), complete heart valve replacement in Sep2017 (replaced with pig valve), pacemaker in Oct2017 and ongoing, thyroid condition and allergies. Concomitant medications included metoprolol from unspecified date in 2017 and ongoing for thyroid condition, amlodipine from unspecified date in 2017 and ongoing for high blood pressure and clarithromycin (CLARITIN [CLARITHROMYCIN]) from unspecified date in 2017 and ongoing for allergies. No vaccines administered on the same date or within four weeks prior to administration of bnt162b2. The patient experienced increased heart rate, four to five days following first dose on unspecified date. She was asleep when her heart rate increased to 200 beats per minute around 20:00 which woke her. She did not see it coming. She was seen in the emergency room, but not admitted to the hospital in response to this event. They did not know at that time what caused this event. While in the emergency room, the patient was given intravenous medication for cardioversion where they stopped her heart and restarted it to get the rhythm back to normal. She does not know the name of the intravenous medication for cardioversion that she was administered. She recovered completely from this event on unknown date. The patient underwent lab tests and procedures which included: in the emergency room visit, kidneys and heart were tested, x-ray was performed, electrocardiogram (EKG), liver and thyroid tested, all of which came back good; and her heart rhythm was fast, and irregular. Therapeutic measure was taken as a result of the event. Outcome of the event was recovered on unspecified date.
This spontaneous report was received from a registered nurse concerning an unknown number of patients of unknown age and gender. The patients' medical history, concurrent conditions and concomitant medications were not reported. On an unspecified date in March 2017 (reported as "starting on or after 06-MAR-2017"), the patients were vaccinated with doses of ROTATEQ, orally, lot # M019707, expiry date: 25-OCT-2017, for prophylaxis (dose number was unknown), which were improperly stored at 11.4 degrees Celsius (C) for 1 hour 10 minutes. A data logger was involved. There was no previous temperature excursion. No adverse effects were reported. This is one of several cases received from the same reporter. Additional information has been requested.; Sender's Comments:  US-009507513-1703USA012132: US-009507513-1703USA011911:
h/a, vomiting, fever of 102 & c/o abdominal pain;
Fever, swollen lymph nodes, minor cough, arthritic pain in back and ribs, possibly triggered an Ankylosing spondylitis flair. Made AS symptoms worse.
No adverse effects reported; the patient was administered an improperly stored dose of Varivax; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 23-OCT-2019, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) lot # S015460, expiration date 20-MAY-2021 (exact dose, site and route of administration were not reported) that was reconstituted with properly stored sterile diluent. Administered dose of vaccine experienced the temperature excursion of 6 to 14 degrees Fahrenheit for 30 minutes. Data logger was involved. There were no previous excursions reported. No adverse effects reported.
Fatigue, aches and pains, pain in upper arm where injection was administered, occasional nausea, mostly tired and achy for 3 days.
Swollen left arm pit, somewhat painful.  I will take ibuprofen and see if that helps.  I'm not really worried, I just thought I should report it.
Right after receiving the shot (first 15 minutes), my face got extremely red and blotchy. Both my ears felt really full.   Later that evening, I had a headache like I've never felt before. That headache would go on to last for 4 weeks with no relief.   A few days later, I started experiencing muscle spasms/muscle weakness. I also felt pins and needles in my fingers and toes. I had extreme neck and back pain as well. It felt like my spine was on fire. I experienced bad brain fog. I also had bad joint pain in my fingers and toes (still do). I couldn't get out of bed and function well for about a month after my shot.   I also started my period days after (I was breastfeeding  a newborn and don't usually get periods for about 6 months postpartum). It lasted for about 4 days. I then had light bleeding about every two weeks. I also started experiencing extreme itchiness. I went to my OB and tested positive for bacterial vaginosis. I have had a hard time getting rid of it since.   I currently still experience strange headaches (off and on), joint pain in my fingers and toes, brain fog, muscle spasms and muscle weakness.
Pt states arm discomfort after receiving flu shot 10/10/13, radiating down to fingers.  Denies redness or swelling at the site.  Advised to contact physician or visit to rule out any other condition.
Side effect; This spontaneous case was reported by a physician and describes the occurrence of IMMUNISATION REACTION (Side effect) in a patient of an unknown age and gender who received mRNA-1273.815 (SPIKEVAX 2023-2024) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. On an unknown date, the patient experienced IMMUNISATION REACTION (Side effect). At the time of the report, IMMUNISATION REACTION (Side effect) outcome was unknown.        For mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not provided. Treatment information was not reported.   Most recent FOLLOW-UP information incorporated above includes: On 16-Oct-2023: Live follow-up received and added secondary reporter.
areas on skin that look like shingles; This case was reported by a consumer via  interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient received dose of Shingles vaccine and experienced several areas on his/her skin that look like they could be shingles. The patient asked this was a possible side effect. The follow-up would not possible as no contact details were available.
Information has been received from a registered nurse concerning a 24 year old female pt who on 10/03/2000 and 11/08/2000 was vaccinated with variella vaccine. The pt then had a titer drawn and had no titer level. On 05/01/2001 and 05/13/2001, the pt was revaccinated with varicella vaccine. Subsequently the pt still did not have titer level. Additional info has been requested.
Chills, horrible headache from 4 hours after the shot until the next afternoon....approximately 24 hours.
have administered second booster dose of the Pfizer  COVID vaccine (Gray cap) to a 15 years old female that was not eligible to get it.; have administered second booster dose of the Pfizer  COVID vaccine (Gray cap) to a 15 years old female that was not eligible to get it.; have administered second booster dose of the Pfizer  COVID vaccine (Gray cap) to a 15 years old female that was not eligible to get it.; Asthma; This is a spontaneous report received from a contactable reporter(s) (Pharmacist) from medical information team.  A 15-year-old female patient received BNT162b2 (BNT162B2), as dose number unknown (2nd booster), single (Batch/Lot number: unknown) at the age of 15 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete, Manufacturer: Unknown), for COVID-19 Immunization; Covid-19 vaccine (DOSE NUMBER UNKNOWN (1st BOOSTER); Manufacturer: Unknown), for COVID-19 Immunization. The following information was reported: OFF LABEL USE (non-serious), IMMUNISATION (non-serious), PRODUCT USE ISSUE (non-serious) and all described as "have administered second booster dose of the Pfizer  COVID vaccine (Gray cap) to a 15 years old female that was not eligible to get it."; ASTHMA (non-serious).  Additional information: It was reported that she had Asthma but not immunocompromised. She was fully immunized and 2nd booster dose was not needed.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
swelling, redness, pain rt arm approx 1" from inj site-first noticed this AM-extends to axilla;pt nl takes Hismanual, Zestril;pt returned to clinic 12DEC96 to report sx & was seeing CNP;